G. Dutschman

发表

Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique.

Yung-chi Cheng, E. Chu, Wei Zhang, 2011, Biochemical pharmacology.

Synthesis and biological evaluation of a series of 2'-fluorinated-2',3'-dideoxy-2',3'-didehydro-(L)-nucleosides.

Y. Cheng, T. Doyle, E. Gullen, 1998, Bioorganic & medicinal chemistry letters.

Quantitation of paclitaxel and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometry.

Yung-chi Cheng, Wei Zhang, G. Dutschman, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture

Yung-chi Cheng, E. Paintsil, S. Grill, 2009, AIDS research and therapy.

Synthesis of 2'-methylene-substituted 5-azapyrimidine, 6-azapyrimidine, and 3-deazaguanine nucleoside analogues as potential antitumor/antiviral agents.

A. Sartorelli, Y. Cheng, T. Lin, 1999, Nucleosides & nucleotides.

Anti-Epstein-Barr Virus (EBV) Activity of β-l-5-Iododioxolane Uracil Is Dependent on EBV Thymidine Kinase

Yung-chi Cheng, C. K. Chu, Ju-sheng Lin, 2000, Antimicrobial Agents and Chemotherapy.

Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.

Y. Cheng, M. Sarngadharan, K. Bastow, 1987, The Journal of biological chemistry.

Acetylenic nucleosides. 4. 1-beta-D-arabinofuranosyl-5-ethynylcytosine. Improved synthesis and evaluation of biochemical and antiviral properties.

Y. Cheng, R. Sharma, M. Bobek, 1987, Journal of medicinal chemistry.

Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.

Chih-Hung Hsu, Shin-Young Park, G. Dutschman, 2004, Molecular pharmacology.

Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells

Y. Cheng, K. Frank, S. Grill, 1984, Antimicrobial Agents and Chemotherapy.

Impact of Novel Human Immunodeﬁciency Virus Type 1 Reverse Transcriptase Mutations P119S and T165A on 4 (cid:1) -Ethynylthymidine Analog Resistance Proﬁle (cid:1)

M. Baba, Guangwei Yang, E. Paintsil, 2009 .

Intracellular Metabolism and Persistence of the Anti-Human Immunodeﬁciency Virus Activity of 2 (cid:2) ,3 (cid:2) -Didehydro-3 (cid:2) -Deoxy-4 (cid:2) -Ethynylthymidine, a Novel Thymidine Analog (cid:1)

M. Baba, W. Lam, E. Paintsil, 2007 .

Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.

C. Hsieh, G. Dutschman, P. Krishnan, 2003, Molecular pharmacology.

Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates.

W. Lam, Z. Jiang, G. Dutschman, 2002, Cancer research.

Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication

Sangwon Lee, Y. Ha, A. Fürstner, 2017, Scientific Reports.

Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate.

W. Hinz, K. Anderson, D. Austin, 2013, Bioorganic & medicinal chemistry letters.

Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase

Y. Cheng, G. Piras, S. Chu, 1995, Antimicrobial agents and chemotherapy.

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.

E. Huang, Y. Cheng, J. Pagano, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.

W. Lam, G. Dutschman, Jieh-Yuan Liou, 2004, Molecular pharmacology.

Anti-Hepatitis B Virus Activity and Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β-l(−)-5-Fluorocytidine

Shwu-Huey Liu, E. Bridges, G. Dutschman, 1998, Antimicrobial Agents and Chemotherapy.

Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues.

M. Kukhanova, Y. Cheng, G. Dutschman, 1998, Cancer research.

Determinants of Individual Variation in Intracellular Accumulation of Anti-HIV Nucleoside Analog Metabolites

W. Lam, V. Northrup, E. Paintsil, 2010, Antimicrobial Agents and Chemotherapy.

Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase.

Y. Cheng, C. Stein, J. Cohen, 1989, The Journal of biological chemistry.

Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4]arene scaffold.

A. Hamilton, E. Gullen, M. Telpoukhovskaia, 2010, Bioorganic & medicinal chemistry letters.

Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity

R. S. Tan, Y. Cheng, B. Zhou, 1987, Journal of virology.

Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.

Y. Cheng, S. Grill, K. Bastow, 1983, The Journal of biological chemistry.

Virus-induced thymidine kinases as markers for typing herpes simplex viruses and for drug sensitivity assays.

R. S. Tan, R. Schinazi, Y. Cheng, 1982, Journal of virological methods.

Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).

Wei Zhang, Xin Li, Min Ye, 2010, Journal of chromatography. A.

Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Y. Cheng, T. Lin, M. Liu, 1994, Journal of medicinal chemistry.

Synthesis of (±)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T)

M. Baba, T. Nitanda, H. Kumamoto, 2005, Nucleosides, nucleotides & nucleic acids.

Synthesis and Biological Evaluation of 2′,3′-Didehydro-2′,3′-Dideoxy-9-Deazaguanosine, a Monophosphate Prodrug and Two Analogues, 2′,3′-Dideoxy-9-Deazaguanosine and 2′,3′-Didehydro-2′,3′-Dideoxy-9-Deazainosine

A. Sartorelli, E. Gullen, G. Dutschman, 2005, Nucleosides, nucleotides & nucleic acids.

Mechanism of Anti-Human Immunodeﬁciency Virus Activity of (cid:2) - D -6-Cyclopropylamino-2 (cid:3) ,3 (cid:3) -Didehydro-2 (cid:3) ,3 (cid:3) -Dideoxyguanosine

K. Anderson, R. Schinazi, C. K. Chu, 2005 .

Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus

Y. Cheng, R. Sharma, L. Nutter, 1987, Antimicrobial Agents and Chemotherapy.

3'-Carbon-Substituted Pyrimidine Nucleosides Having a 2',3'-dideoxy and 2',3'-didehydro-2',3'-dideoxy Structure: Synthesis and Antiviral Evaluation

H. Kumamoto, Hiromichi Tanaka, G. Dutschman, 2006, Antiviral chemistry & chemotherapy.

Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.

Y. Cheng, E. Gullen, E. Bridges, 1996, Biochemical pharmacology.

Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.

Y. Cheng, T. Lin, M. Liu, 1994, Biochemical pharmacology.

Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT.

K. Anderson, M. Baba, Guangwei Yang, 2007, Antiviral research.

Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.

M. Baba, E. Gullen, K. Haraguchi, 2008, Journal of medicinal chemistry.

Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine.

M. Baba, T. Nitanda, K. Haraguchi, 2003, Bioorganic & medicinal chemistry letters.

Design and Synthesis of 2‘,3‘-Dideoxy- 2‘,3‘-didehydro-β-l-cytidine (β-l-d4C) and 2‘,3‘-Dideoxy-2‘,3‘-didehydro-β-l-5- fluorocytidine (β-l-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in Vitro

E. Gullen, G. Dutschman, Tai-shun Lin, 1996 .

Comparison of the Phosphorylation of 4′-Ethynyl 2′,3′-Dihydro-3′-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs

Chih-Hung Hsu, M. Baba, Guangwei Yang, 2007, Antimicrobial Agents and Chemotherapy.

Mechanism of Inhibition of Human Immunodeﬁciency Virus Type 1 Reverse Transcriptase by a Stavudine Analogue, 4 (cid:2) -Ethynyl Stavudine Triphosphate (cid:1)

M. Baba, Guangwei Yang, Hiromichi Tanaka, 2008 .

Synthesis and Biological Evaluation of 1,3-Oxathiolane 5-Azapyrimidine, 6-Azapyrimidine, and Fluorosubstituted 3-Deazapyrimidine Nucleosides

Maohui Luo, A. Sartorelli, E. Gullen, 2000, Nucleosides, Nucleotides & Nucleic Acids.

Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells.

Y. Cheng, R. Kilkuskie, K. Lee, 1990, Journal of natural products.

Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid.

Y. Cheng, R. Kilkuskie, K. Lee, 1989, Journal of natural products.

Synthesis and antiviral activity of helioxanthin analogues.

E. Huang, D. Austin, Yashang Lee, 2005, Journal of medicinal chemistry.

Novel Role of 3-Phosphoglycerate Kinase, a Glycolytic Enzyme, in the Activation of L-Nucleoside Analogs, a New Class of Anticancer and Antiviral Agents*

Elizabeth A. Gullen, Wing Lam, W. Lam, 2003, Journal of Biological Chemistry.

Prevention of binding of rgp120 by anti-HIV active tannins.

P. S. Pine, Y. Cheng, K. Lee, 1992, Biochemical pharmacology.

Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys.

Y. Cheng, H. Thompson, E. Varnell, 1991, Antiviral research.

Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.

R. T. Walker, E. De Clercq, Y. Cheng, 1981, Molecular pharmacology.

Alizarine derivatives as new dual inhibitors of the HIV‐1 reverse transcriptase‐associated DNA polymerase and RNase H activities effective also on the RNase H activity of non‐nucleoside resistant reverse transcriptases

P. Markt, E. Tramontano, G. Floris, 2011, The FEBS journal.

Synthesis and biological evaluation of L- and D-configuration 1,3-dioxolane 5-azacytosine and 6-azathymine nucleosides.

A. Sartorelli, Y. Cheng, T. Lin, 2000, Bioorganic & medicinal chemistry letters.

Novel 4′-Substituted Stavudine Analog with Improved Anti-Human Immunodeficiency Virus Activity and Decreased Cytotoxicity

M. Baba, E. Gullen, S. Grill, 2004, Antimicrobial Agents and Chemotherapy.

Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human UMP/CMP Kinase Is Differentially Regulated by ATP and Magnesium

Chih-Hung Hsu, G. Dutschman, Jieh-Yuan Liou, 2005, Molecular Pharmacology.

Synthesis and comparative evaluation of two antiviral agents: β-l-Fd4C and β-d-Fd4C

T. Doyle, E. Gullen, Stanley L. Lin, 1998 .

Behavior of Thymidylate Kinase toward Monophosphate Metabolites and Its Role in the Metabolism of 1-(2′-Deoxy-2′-Fluoro-β-l-Arabinofuranosyl)-5-Methyluracil (Clevudine) and 2′,3′-Didehydro-2′,3′-Dideoxythymidine in Cells

B. Degrève, W. Lam, Rong Hu, 2005, Antimicrobial Agents and Chemotherapy.

Syntheses and biological evaluations of 3'-deoxy-3'-C-branched-chain-substituted nucleosides.

Y. Cheng, W. Prusoff, T. Lin, 1993, Journal of medicinal chemistry.

Design and Synthesis of 2′,3′‐Dideoxy‐2′,3′‐didehydro‐β‐L‐ cytidine (β‐L‐d4C) and 2′,3′‐Dideoxy‐2′,3′‐didehydro‐β‐L‐5‐ fluorocytidine (β‐L‐Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in vitro.

E. Gullen, G. Dutschman, M. Luo, 1996 .

Synthesis of a Series of Purine 2′,3′‐Dideoxy‐L‐nucleoside Analogues as Potential Antiviral Agents.

G. Dutschman, M. Luo, Mao Liu, 1996 .

SYNTHESIS OF A SERIES OF PURINE 2',3'-DIDEOXY-L-NUCLEOSIDE ANALOGUES AS POTENTIAL ANTIVIRAL AGENTS

G. Dutschman, M. Luo, Mao Liu, 1995 .

Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro

G. Dutschman, S. Pai, Cheng Yung-Chi, 1994 .

Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Thymidine Analog

M. Baba, W. Lam, E. Paintsil, 2007, Antimicrobial Agents and Chemotherapy.

Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β-l(−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus β-d(+) Nucleoside Analogs In Vitro

M. Kukhanova, E. Gullen, Shwu-Huey Liu, 1998, Antimicrobial Agents and Chemotherapy.

Impact of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations P119S and T165A on 4′-Ethynylthymidine Analog Resistance Profile

Jimin Wang, M. Baba, Guangwei Yang, 2009, Antimicrobial Agents and Chemotherapy.

Mechanism of Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase by a Stavudine Analogue, 4′-Ethynyl Stavudine Triphosphate

Jimin Wang, M. Baba, Guangwei Yang, 2008, Antimicrobial Agents and Chemotherapy.

Synthesis of 4'-Ethynyl-2'-deoxy-4'-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI.

M. Baba, J. Balzarini, H. Abe, 2011, ACS medicinal chemistry letters.

A NEW APPROACH TO THE SYNTHESIS OF 4′-CARBON-SUBSTITUTED NUCLEOSIDES: DEVELOPMENT OF A HIGHLY ACTIVE ANTI-HIV AGENT 2′, 3′-DIDEHYDRO-3′-DEOXY-4′-ETHYNYLTHYMIDINE

M. Baba, T. Nitanda, K. Haraguchi, 2005, Nucleosides, nucleotides & nucleic acids.

Synthesis and Anti‐HIV Activity of 4′‐Cyano‐2′,3′‐didehydro‐3′‐deoxythymidine

M. Baba, T. Nitanda, Y. Itoh, 2004, Nucleosides, nucleotides & nucleic acids.

Mechanism of Anti-Human Immunodeficiency Virus Activity of β-d-6-Cyclopropylamino-2′,3′-Didehydro-2′,3′-Dideoxyguanosine

K. Anderson, H. McClure, R. Schinazi, 2005, Antimicrobial Agents and Chemotherapy.

Favorable interaction of β-l(−) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus

E. Gullen, E. Bridges, G. Dutschman, 1996 .

In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.

J. Mellors, Y. Cheng, E. Tramontano, 1992, Molecular pharmacology.

Studies of the Pharmacokinetics and Toxicology of 2′,3′-Dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-Dideoxy-β-L-cytidine (β-L-ddC) In Vivo; and Synthesis and Antiviral Evaluations of 2′,3′-Dideoxy-β-L-5-azacytidine

G. Dutschman, S. Pai, M. Luo, 1995 .

Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates

Wing Lam, W. Lam, Yung-Chi Cheng, 2002, The Journal of Biological Chemistry.

A Novel Class of meso-Tetrakis-Porphyrin Derivatives Exhibits Potent Activities against Hepatitis C Virus Genotype 1b Replicons In Vitro

B. Lindenbach, A. Hamilton, E. Gullen, 2009, Antimicrobial Agents and Chemotherapy.

Synthesis and Biological Evaluation of L‐ and D‐Configurations of 2′,3′‐Dideoxy‐4′‐C‐methyl‐3′‐oxacytidine Analogues.

Maohui Luo, A. Sartorelli, Y. Cheng, 2001 .

Metabolism and mode of inhibition of varicella-zoster virus by L-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase.

Y. Cheng, C. K. Chu, E. Gullen, 2000, Molecular pharmacology.

2′3′Dideoxy-3′Thiacytidine (SddC) as an Anti-Human Hepatitis B Virus (HBV) and Anti-Human Immunodeficiency Virus (HIV) Agent

S. Doong, G. Dutschman, Jing Zhou, 1992 .

The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.

V. Skalski, Y. Cheng, C. N. Chang, 1993, The Journal of biological chemistry.

Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases

Y. Cheng, K. Watanabe, G. Dutschman, 1981, Antimicrobial Agents and Chemotherapy.

Synthesis of a Highly Active New anti‐HIV Agent 2′,3′‐Didehydro‐3′‐deoxy‐4′‐ethynylthymidine.

M. Baba, T. Nitanda, K. Haraguchi, 2004 .

Biological and biochemical effects of 2'-azido-2'-deoxyarabinofuranosylcytosine on human tumor cells in vitro.

R. S. Tan, Y. Cheng, D. Derse, 1981, Cancer research.

Time-dependent action of 5-propyl deoxyuridine as antiherpes simplex virus type 1 and type 2 agents.

Y. Cheng, S. Grill, G. Dutschman, 1979, Biochemical pharmacology.

Synthesis and Biological Evaluation of L‐ and D‐Configurations of 2′,3′‐Dideoxy‐4′‐C‐methyl‐3′‐oxacytidine Analogues.

A. Sartorelli, E. Gullen, G. Dutschman, 2001 .

Preparation and biological activity of various 3-deazapyrimidines and related nucleosides.

R. K. Robins, B. Currie, G. Dutschman, 1973, Journal of medicinal chemistry.

Cytotoxicity of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine and its relationship to deoxycytidine deaminase.

R. S. Tan, Y. Cheng, J. Ruth, 1983, Biochemical pharmacology.

Differential binding affinities of sugar-modified derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine for herpes simplex virus-induced and human cellular deoxythymidine kinases.

E. De Clercq, Y. Cheng, G. Dutschman, 1984, Biochemical pharmacology.

Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine.

A. Bloch, G. Grindey, G. Dutschman, 1974, Cancer research.

Synthesis and anti-hiv-1 activities of 6-arylthio and 6-arylselenoacyclonucleosides

G. Piras, S. Chu, G. Dutschman, 1994 .

Anti-herpes simplex virus activity of 5-substituted 2-pyrimidinone nucleosides

Y. Cheng, M. Fisher, S. Efange, 1989, Antimicrobial Agents and Chemotherapy.

Cytidine 3',5'-monophosphate (cyclic CMP). II. Initiation of leukemia L-1210 cell growth in vitro.

A. Bloch, G. Dutschman, R. Maue, 1974, Biochemical and biophysical research communications.

A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).

J. Mellors, Y. Cheng, E. Tramontano, 1993, Molecular pharmacology.

SYNTHESIS OF HALOGEN-SUBSTITUTED 3-DEAZAADENOSINE AND 3-DEAZAGUANOSINE ANALOGUES AS POTENTIAL ANTITUMOR/ANTIVIRAL AGENTS

A. Sartorelli, E. Gullen, G. Dutschman, 2001, Nucleosides, nucleotides & nucleic acids.

Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).

A. Townsend, Y. Cheng, D. Cooney, 1985, Cancer research.

Synthesis and Biological Evaluation of 1,3-Oxathiolane 5-Azapyrimidine, 6-Azapyrimidine, and Fluorosubstituted 3-Deazapyrimidine Nucleosides.

A. Sartorelli, E. Gullen, G. Dutschman, 2000 .

Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine.

Y. Yen, Y. Cheng, B. Zhou, 1994, Cancer research.

Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides

C. Crews, J. Hines, R. Ju, 2010, Journal of Pharmacology and Experimental Therapeutics.

Blocking HIV-1 entry by a gp120 surface binding inhibitor.

A. Hamilton, Chin-Ho Chen, L. Tsou, 2012, Bioorganic & medicinal chemistry letters.

Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.

Y. Cheng, M. Fisher, M. G. Nair, 1985, Cancer research.

A phase I study of PHY906 as a modulator of irinotecan (CPT-11) in patients with advanced solid tumors.

M. Saif, E. Chu, Kristin Kaley, 2010 .